Event Details
| Title: | Elan-Wyeth Symposium: Immunotherapy for Treatment of AD & PD |
| Date: | Thursday, March 15, 2007 |
| File: | Description: |
 | Aß Immunotherapy: Use of Monoclonal Antibodies for Potential Treatment and Amelioration of AD Neuropathology |
 | |
| |
| Clinical Progress in the Immunotherapeutic Approach to Alzheimer's Disease |
| |
| |
| Alpha-Synuclein Clearance and Vaccination Strategies in the Development of New Treatments of Parkinson’s Disease |
| |
| |
| Potential Mechanisms of Aß Plaque Clearance in Patients Immunized with Aß |
| |
| |
| Long Term Follow Up of Patients Immunized with AN1792(QS-21): Reduced Functional Decline in Antibody Responders |
| |
| |
| Elan Poster Presentation | |
| Mapping Determinants for A-beta production in PS1 and PS2 |